1. Home
  2. PMVP vs ANVS Comparison

PMVP vs ANVS Comparison

Compare PMVP & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMVP
  • ANVS
  • Stock Information
  • Founded
  • PMVP 2013
  • ANVS 2008
  • Country
  • PMVP United States
  • ANVS United States
  • Employees
  • PMVP N/A
  • ANVS N/A
  • Industry
  • PMVP Medicinal Chemicals and Botanical Products
  • ANVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PMVP Health Care
  • ANVS Health Care
  • Exchange
  • PMVP Nasdaq
  • ANVS Nasdaq
  • Market Cap
  • PMVP 85.5M
  • ANVS 92.6M
  • IPO Year
  • PMVP 2020
  • ANVS 2020
  • Fundamental
  • Price
  • PMVP $1.43
  • ANVS $2.95
  • Analyst Decision
  • PMVP Strong Buy
  • ANVS Strong Buy
  • Analyst Count
  • PMVP 3
  • ANVS 6
  • Target Price
  • PMVP $5.33
  • ANVS $29.67
  • AVG Volume (30 Days)
  • PMVP 158.0K
  • ANVS 548.9K
  • Earning Date
  • PMVP 02-27-2025
  • ANVS 03-31-2025
  • Dividend Yield
  • PMVP N/A
  • ANVS N/A
  • EPS Growth
  • PMVP N/A
  • ANVS N/A
  • EPS
  • PMVP N/A
  • ANVS N/A
  • Revenue
  • PMVP N/A
  • ANVS N/A
  • Revenue This Year
  • PMVP N/A
  • ANVS N/A
  • Revenue Next Year
  • PMVP N/A
  • ANVS N/A
  • P/E Ratio
  • PMVP N/A
  • ANVS N/A
  • Revenue Growth
  • PMVP N/A
  • ANVS N/A
  • 52 Week Low
  • PMVP $1.32
  • ANVS $2.88
  • 52 Week High
  • PMVP $2.26
  • ANVS $20.00
  • Technical
  • Relative Strength Index (RSI)
  • PMVP 47.66
  • ANVS 20.82
  • Support Level
  • PMVP $1.37
  • ANVS $2.99
  • Resistance Level
  • PMVP $1.46
  • ANVS $5.50
  • Average True Range (ATR)
  • PMVP 0.05
  • ANVS 0.34
  • MACD
  • PMVP 0.01
  • ANVS -0.18
  • Stochastic Oscillator
  • PMVP 78.57
  • ANVS 3.59

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

Share on Social Networks: